India to fund capacity boost at Serum Institute as vaccines run short
India is set to accept the Serum Institute of India's (SII) request for a 30 billion rupee ($400 million) grant to boost its capacity to make the AstraZeneca (AZN.L) COVID-19 vaccine, a government source with knowledge of the matter said.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.